University of California, San Francisco
San Francisco, California, 94143, United States
NCT Number: NCT01354041
The primary objective of this pilot study is to examine the feasibility and acceptability of a randomized, controlled study of a mindfulness and values-based living intervention targeted at reducing fear of recurrence in breast cancer survivors compared to treatment as usual control. Furthermore, the secondary objective of this randomized, controlled pilot study is to determine preliminary efficacy and effect size of the mindfulness and values-based living intervention compared to the treatment as usual control condition in reducing fear of recurrence in breast cancer survivors.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Phase 1
San Francisco, California, 94143, United States
Fear of cancer recurrence (FCR) is pervasive, distressing and undermines quality of life in cancer survivors. For subgroups of survivors, FCR is implicated in both treatment non-adherence and medical over-utilization. Although some degree of FCR is nearly universal among cancer patients, effective psychological interventions have been understudied. Educational and cognitive approaches that have relied on reassurance may feed into the anxiety by encouraging experiential avoidance, according to behavioral theories of anxiety. Mindfulness and values based living approaches teach techniques for reducing experiential avoidance allowing patients to break this cycle and focus on functional, satisfying lives. Interventions based on these techniques offer promise for addressing FCR in breast cancer survivors.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Seven weekly sessions of Acceptance and Commitment Therapy (ACT) intervention
Other names: ACT
Time frame: Weeks 0, 6, 10, 30
Multi-dimensional fear of recurrence measure.
Time frame: Weeks 0, 6, 10, 30
Validated measure of anxiety.
University of California, San Francisco
Other
A Pilot Intervention to Address Fear of Recurrence in Breast Cancer Survivors
Acronym: WiLLoW
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07657728
Cancer Recurrence
Gorgan, Golestan Province, Iran
View Trial DetailsNCT07167147
Cancer Recurrence, Colon Adenocarcinoma
Taoyuan, Taiwan
View Trial DetailsNCT04596865
Adenocarcinoma, Ampullary Cancer
Clayton, Victoria, Australia
View Trial DetailsNCT04257240
Cancer Recurrence, Cardiovascular Diseases
View Trial Details